Kevin P. Foley

Dr. Foley brings to Ranok over 20 years’ experience in drug discovery, preclinical and clinical development, with an emphasis on cancer, immuno-oncology and inflammatory diseases. He also has a long-standing research interest in protein homeostasis and the ubiquitin-proteasome system. In prior roles at FORMA Therapeutics, GlaxoSmithKline, Synta Pharmaceuticals, Millennium Pharmaceuticals and ZymoGenetics, he had a successful track record of advancing innovative therapies into the clinic, with more than 10 clinical-stage programs to his credit. Dr. Foley conducted his post-doctoral training at the Fred Hutchinson Cancer Research Center and received his Ph.D. in Molecular Biology from Northwestern University.